Search Results 831-840 of 18608 for Relapse
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
... relapsed B-cell lymphoma. Chemotherapy. Chemotherapy treats ... You may have repeat blood and imaging tests and, if needed, biopsies, to check for relapse.
... relapsed and refractory disease for patients with hematologic malignancies. For example, in relapsed/refractory multiple myeloma, CAR-T cell therapy is only ...
... relapse in diffuse large B-cell lymphoma. Blood Cancer J. 2025 Jul 12; 15 (1):120 Epub 2025 July 12. View PubMed; Atallah-Yunes SA, Rees MJ, Mwangi R, Kuchler ...
... relapsed/refractory AML CD33 positive patients in the USA. Contact: B1761026@iconplc.com. A Study to Evaluate Stereotactic Body Radiation Therapy (SBRT) vs ...
The purpose of this research study is to better understand if diet and metabolism are connected with MS relapses and disease progress in patients with pediatric ...
Pittock] Well I think the future is bright. We've made dramatic advances. We now have drugs that reduce the chances of a clinical relapse by 98.5%. That's ...
... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...
Patients with large B-cell lymphoma who do not respond to an anthracycline-based front-line chemoimmunotherapy or who show evidence of relapse within 12 ...
... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ... Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.